The LIMS Acquisition E-Guide for Laboratories
An executive e‑guide for laboratory leaders navigating LIMS decisions amid private equity acquisition, ownership transitions, or roadmap uncertainty.
Laboratories invest in systems designed to support decades of regulated operations. Private equity investment, by contrast, operates on defined ownership and exit cycles. When these timelines collide, they can introduce strategic, operational, and compliance risk for the lab.
This e‑guide explores how acquisition cycles can impact LIMS stability, validation confidence, and long‑term planning. It also provides a clear, practical framework to help leaders recognize early warning signs, assess risk with confidence, and evaluate more stable, future‑ready LIMS alternatives.
Fill out the form to download our E-Guide
Why Clinisys™ is a Trusted LIMS Partner
Clinisys™ is a global provider of laboratory informatics solutions, supporting healthier and safer communities for more than 45 years. Every day, millions of laboratory results and data insights are generated through our platform and cloud‑based solutions, which are used by more than 7,000 laboratories across 39 countries.
45+
years of laboratory informatics experience.
39
countries across North America, South America, UK, Europe, Middle East, and Australia.
7,000+
customers worldwide using Clinisys™ solutions.
1,750+
lab informatics professionals based in 12 countries.
In 2012
Clinisys™ became part of Roper Technologies (NASDAQ: ROP), founded in 1890 and generating approximately $7B in revenue from market‑leading niche businesses.
13
globally recognized certifications including ISO 13485/9001, MDSAP, ISO 27001/27017/27018, ISO 20000, Cyber Essentials & Cyber Essentials Plus, ENS, ONC, Qualiopi, and SOC 2 Type 2.
22
specialist disciplines supported across 9 major lab industry sectors.
12
offices and support centers serving customers worldwide across products in 5 languages.
